Abbott introduces Sekisui CP3000 fully automated coagulation system for accurate test results
Sep 06 2017 Read 1400 Times
Abbott announced that the Sekisui CP3000 coagulation system, a fully automated analyser that tests bleeding and clotting function in blood, is now available in Europe, the Middle East, and Asia Pacific. Abbott is the exclusive global distributor of the CP3000 coagulation system in the U.S, Europe and other countries that recognise CE Mark and has non-exclusive distribution rights with Sekisui in China, Hong Kong, Japan and Macau.
"The launch of the CP3000 coagulation system is an important milestone in our ongoing efforts to improve care for people around the world. For many of our customers, quickly obtaining reliable test results is critical to their clinical decision making," said Luis de Luzuriaga, Divisional Vice President and General Manager for Abbott’s haematology business. "Abbott is committed to offering testing solutions, like the CP3000 system, to healthcare providers who provide accurate results and improve the operational performance of their laboratories."
The CP3000 coagulation system seamlessly integrates with Abbott’s suite of informatics solutions, which help accelerate efficiency in high test volume laboratories where resources may be limited and space and time is at a premium. Capabilities like Abbotts AlinIQ informatics and service offerings streamline operations and provide intelligent laboratory insights through common reporting and dashboard views, make it easy for healthcare providers to read and interpret patient results. The system also connects to the ACCELERATOR a3600 automation track, which provides additional flexibility to meet the needs of the laboratory.
Coagulation tests measure the blood’s ability to clot. Clotting disorders may be a sign of liver disease, thrombophilia (excessive clotting), or haemophilia (inability to clot normally). These tests aid physicians in assessing the patients’ risk of excessive bleeding or clotting and in determining the patient care pathway. Coagulation tests are also performed to monitor patients who are taking medications that can affect clotting.
Delays in coagulation testing are often related to sample errors and manual errors in the testing process. CP3000 coagulation system provides automated, standardised sample management, and can flag unsuitable samples at the start of testing. The system offers an expanded menu of barcoded reagents to reduce data entry errors. With a unique ability to visualise and automate Mixing Studies, the CP3000 coagulation system can help clinicians quickly interpret results.
"The CP3000 coagulation system has been a great addition to our lab. It does not occupy a lot of space, and its automated processes and user-friendly design have reduced the burden on our lab staff and pathologists. We have been pleased with how quickly the system produces accurate results that are used to guide treatment decisions for our patients," said Dr Chandra Poonam, Laboratory Director at Gulf Diagnostic Center Hospital in Abu Dhabi, United Arab Emirates.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Determination of heroin in street drug samples with printable surface enhanced Raman scattering (P-SERS) - Advances in Protein Sample Preparation: Centrifugation i...
View all digital editions
Jan 28 2019 Dubai International Convention & Exhibition Centre
Jan 30 2019 Tokyo, Japan
Jan 31 2019 Paris, France
Feb 02 2019 Washington, DC, USA.
Feb 04 2019 Dubai, UAE